Yoshihito Atsumi

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 309 citations

Medicine, Cardiology, Internal Medicine +13

Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus

Hiroaki Yoshida, Satoru Kuriyama, Yoshihito Atsumi et al. · Kidney International · 1996 · 192 citations · Full text

Medicine, Genetics, Molecular Genetics +9

Role of Glycemic Control and Blood Pressure in the Development and Progression of Nephropathy in Elderly Japanese NIDDM Patients

Yasushi Tanaka, Yoshihito Atsumi, Kenpei Matsuoka et al. · Diabetes Care · 1998 · 96 citations

Medicine, Internal Medicine, Nephrology +12

Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study

Nobuya Inagaki, Yoshihito Atsumi, Tomonori Oura et al. · Clinical Therapeutics · 2012 · 84 citations

Medicine, Pharmacology, Pharmacotherapy +16

Diabetes Associated With a Novel 3264 Mitochondrial tRNALeu(UUR) mutation

Yoshihiko Suzuki, Susumu Suzuki, Yoshinori Hinokio et al. · Diabetes Care · 1997 · 70 citations

Life Sciences, Genetics, Molecular Genetics +17